首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Optimizing centrifugation of coagulation samples in laboratory automation
【24h】

Optimizing centrifugation of coagulation samples in laboratory automation

机译:在实验室自动化中优化混凝样品的离心

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: High acceleration centrifugation conditions are used in laboratory automation systems to reduce the turnaround time (TAT) of clinical chemistry samples, but not of coagulation samples. This often requires separate sample flows. The CLSI guideline and manufacturers recommendations for coagulation assays aim at reducing platelet counts. For measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) platelet counts (Plt) below 200 × 109/L are recommended. Other coagulation assays may require even lower platelet counts, e.g., less than 10 × 109/L. Unifying centrifugation conditions can facilitate the integration of coagulation samples in the overall workflow of a laboratory automation system. Methods: We evaluated centrifugation conditions of coagulation samples by using high acceleration centrifugation conditions (5 min; 3280 × g) in a single and two consecutive runs. Results of coagulation assays [PT, APTT, coagulation factor VIII (F. VIII) and protein S] and platelet counts were compared after the first and second centrifugation. Results: Platelet counts below 200 × 109/L were obtained in all samples after the first centrifugation and less than 10 × 109/L was obtained in 73% of the samples after a second centrifugation. Passing-Bablok regression analyses showed an equal performance of PT, APTT and F. VIII after first and second centrifugation whereas protein S measurements require a second centrifugation. Conclusions: Coagulation samples can be integrated into the workflow of a laboratory automation system using high acceleration centrifugation. A single centrifugation was sufficient for PT, APTT and F. VIII whereas two successive centrifugations appear to be sufficient for protein S activity.
机译:背景:实验室自动化系统中使用了高加速度离心条件,以减少临床化学样品的周转时间(TAT),但不减少凝血样品的周转时间。这通常需要单独的样品流。 CLSI指南和制造商关于凝血测定的建议旨在减少血小板数量。为了测量凝血酶原时间(PT)和活化的部分凝血活酶时间(APTT),建议血小板计数(Plt)低于200×109 / L。其他凝血测定可能需要更低的血小板计数,例如小于10×109 / L。统一的离心条件可以促进将凝结样品整合到实验室自动化系统的整个工作流程中。方法:我们通过高加速离心条件(5分钟; 3280×g),以单次和连续两次运行来评估凝结样品的离心条件。在第一次和第二次离心后,比较凝血测定的结果[PT,APTT,凝血因子VIII(F. VIII)和蛋白S]和血小板计数。结果:第一次离心后,所有样品中的血小板计数均低于200×109 / L,第二次离心后,其中73%的样品中血小板计数低于10×109 / L。 Passing-Bablok回归分析显示,在第一次和第二次离心后,PT,APTT和F.VIII具有相同的性能,而蛋白质S的测量需要第二次离心。结论:使用高加速度离心可以将凝血样品整合到实验室自动化系统的工作流程中。一次离心足以用于PT,APTT和F.VIII,而两次连续离心似乎足以用于蛋白S的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号